SK bioscience Co.,Ltd.

KRX:302440.KS

53800 (KRW) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Operating Activities:
Net Income -11,408.895-13,717.9954,169.61148,391.961-15,975.996-14,267.85627,741.56320,778.12946,125.94227,806.315183,965.53176,437.30152,811.7841,924.6659,878.28430,562.865-2,527.673-5,023.7643,751.6135,228.12813,951.618-8,253.955-7,461.891
Depreciation & Amortization 9,074.3799,129.1879,096.3858,875.0978,522.9918,270.237,848.6937,146.8986,436.6395,804.1795,074.6124,830.3544,497.3274,373.0124,315.1464,179.6664,107.0163,925.6083,665.8873,649.343,621.1643,606.8473,333.994
Deferred Income Tax 00000000000000-2,267.2164,536.487-220.229-2,768.9067,586.412-11,077.0642,611.889-4,708.2990
Stock Based Compensation 0000000000000075.06350.27675.05975.05975.0675.05975.05975.0590
Change In Working Capital -13,019.548-4,592.0162,005.45327,419.456-62,805.003-45,011.602-14,389.511-18,660.456-39,377.031-135,951.66776,994.088-154,751.34423,747.91898,010.26768,974.59619,839.806-9,608.03-12,798.66626,862.809-18,570.06-6,802.436,571.16820,192.917
Accounts Receivables 3,966.525-4,375.14246,522.49634,299.703-35,597.37825,942.755-23,278.80418,531.163-30,619.262-9,280.513125,242.934-39,455.124-82,896.3590000000000
Change In Inventory -13,771.082-8,731.89162,821.949,439.684-41,574.123-17,799.188-14,483.89-50,494.191-18,474.487-12,777.275-3,986.119-31,369.954-32,729.643-2,251.387-7,256.6822,165.462-14,497.145-11,985.025,457.2256,831.844-10,422.819-8,754.121689.73
Change In Accounts Payables 2,857.035,156.896-6,942.2194,315.671-1,080.429-3,976.121-22,271.46414,938.8452,603.761-48,029.86-432.16322,504.12528,912.4360000000000
Other Working Capital -6,072.0213,358.127-40,396.724-60,635.60215,446.927-49,179.04845,644.647-1,636.2737,112.957-123,174.39280,980.207-123,381.3956,477.561100,261.65476,231.27817,674.3444,889.115-813.64621,405.584-25,401.9043,620.38915,325.28919,503.187
Other Non Cash Items 437.4243,822.855-13,808.30460,605.089-33,628.017-22,513.13298,260.712670.661-41,094.228-48,373.57971,561.479132,044.143-95,555.03710,627.5921,194.1023,585.108-1,133.953898.09838.19810,773.079-8,802.6181,168.5615,545.634
Operating Cash Flow -40,012.925-31,566.47461,463.144145,291.602-103,886.025-73,522.3643,729.9139,935.231-27,908.678-150,714.751337,595.70958,560.454-14,498.012154,935.53682,169.97263,054.208-9,307.81-15,692.57942,779.98-9,921.5184,654.682-1,540.61921,610.654
Investing Activities:
Investments In Property Plant And Equipment -10,261.181-75,317.511-13,350.736-18,529.716-11,152.184-7,262.854-7,537.162-12,734.552-32,615.442-23,602.288-18,335.165-10,449.689-9,701.038-5,983.668-5,019.39-2,496.539-1,017.076-1,664.565-3,214.774-5,998.687-10,215.033-4,539.914-2,305.934
Acquisitions Net 10.9660111,396.3500.5350034.5660-297.5970-682.307-205.857-130.0500000000
Purchases Of Investments -2,956.800-111,396.350-0.53500-34.566-1,000.087-303,002.275-17,884.98741,641.719-1,106,361.469-68,195.80200000000
Sales Maturities Of Investments 111,710.273135,916.631-164,990.673-9,528.577148,955.776144,336.919111,727.225-5,311.409-23,367.095270,003.484990098.187,236.5811,782.107-21,575.2917,486.90915,568.314-24,623.31319,531.927-2,890.60929,001.9780
Other Investing Activites -54.76344.059-111,367.2820.012-2,413.468-1,088.821-118-903.284-806.066311.216-87577.608195.464768.052-34,059.545343.401116.557202.604688.8625-11,326.001
Investing Cash Flow 98,438.52960,604.085-178,337.35-139,425.573137,823.604134,660.597103,101.243-18,163.961-56,885.82244,595.043-320,333.821-28,421.67631,934.161-1,105,118.949-70,795.083-58,131.3756,813.23414,020.306-27,635.48313,539.24-13,016.7824,467.064-13,631.935
Financing Activities:
Debt Repayment -3,143.528-80,00000-38,003.998-46,549.996-5,995.557-48,000-38,541.670-1,887.089-11,0000-22,68400-405.306-251.453-14,271.95-3,009.281-3,163.931-2,990.324-5,000
Common Stock Issued 00397.599000001,708.169909.77700-940.001984,195.83000000000
Common Stock Repurchased 00000000000000000000000
Dividends Paid 00000000000000000000000
Other Financing Activities -3,143.5280-3,010.77702,415.602-1,858.575-2,516.526-1,940.7437,040.871-1,073.1561,350.74310,852.056-540.206-967.047-632.373-249.68900000010,981.864
Financing Cash Flow -3,143.52877,009.144-2,613.178-2,972.471-35,588.396-48,408.571-8,512.083-49,940.7438,749.04-163.38-536.346-147.944-1,480.206960,544.783-632.373-249.689-405.306-251.453-14,271.95-3,009.281-3,163.931-2,990.3245,981.864
Other Information:
Effect Of Forex Changes On Cash 1,391.2021,827.486-1,000.782865.6852,748.4754,639.789-561.871-16.63517.766-1.13122.2520-0000000000-98,000
Net Change In Cash 56,673.279107,874.241-120,488.1673,759.2441,097.65817,369.455137,757.202-58,186.105-46,027.69293,715.78116,747.79529,990.83415,955.94310,361.36910,742.5164,673.144-2,899.882-1,923.727872.546608.441-11,526.02919,936.121-84,039.418
Cash At End Of Period 291,573.159234,899.88127,025.639247,513.805243,754.562242,656.903225,287.44887,530.247145,716.351191,744.04398,028.26181,280.46751,289.63235,333.6924,972.32114,229.8059,556.66112,456.54214,380.26913,507.72312,899.28224,425.3114,489.19